• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类前列腺腺瘤中的自主神经受体。

Autonomic receptors in human prostate adenomas.

作者信息

Gup D I, Shapiro E, Baumann M, Lepor H

机构信息

Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri.

出版信息

J Urol. 1990 Jan;143(1):179-85. doi: 10.1016/s0022-5347(17)39906-8.

DOI:10.1016/s0022-5347(17)39906-8
PMID:1688458
Abstract

Radioligand receptor binding techniques were used to characterize alpha 1 adrenergic, alpha 2 adrenergic and muscarinic cholinergic (MCh) binding sites in human prostate adenomas obtained from men with symptomatic and asymptomatic benign prostatic hyperplasia (BPH). Prostate adenoma specimens were obtained from nine men with asymptomatic BPH undergoing cystoprostatectomy, 11 men with symptomatic BPH undergoing open prostatectomy, and 11 men with symptomatic BPH undergoing transurethral resection of the prostate (TURP). A quantitative symptoms score analysis and urinary flow rate determinations documented the absence of bladder outlet obstruction in men undergoing cystoprostatectomy and confirmed the presence of bladder outlet obstruction in men undergoing prostatectomy. The mean equilibrium dissociation constants (Kd) and the mean densities of 125I-Heat (alpha 1 adrenergic) and 3H-NMS (MCh) binding sites were similar in tissue homogenates obtained from men with asymptomatic and symptomatic BPH. The mean Kd of 3H-Rauwolscine (3H-Ra) was significantly greater in the prostatectomy specimens obtained from men with symptomatic BPH compared to the specimens obtained from men with asymptomatic BPH (p less than 0.05). The density of 3H-Ra (alpha 2 adrenergic) binding sites was significantly greater in the prostate adenomas obtained from men with symptomatic BPH compared to the prostate adenomas obtained from men with asymptomatic BPH (p less than 0.05). The difference in alpha 2 adrenoceptor density was accounted for by an increased receptor density in the open prostatectomy specimens. There was no significant correlation between alpha 2 adrenergic, alpha 1 adrenergic, and MCh receptor densities and prostate weight or patient age. This study indicates that the development of infravesical obstruction in men with BPH is not related to upregulation or altered binding affinity of alpha 1 adrenergic or MCh receptor binding sites. The significance of the observed upregulation of alpha 2 adrenoreceptors in the prostate adenomas obtained from men undergoing open prostatectomy is unknown, and requires further investigation.

摘要

采用放射性配体受体结合技术,对从有症状和无症状良性前列腺增生(BPH)男性患者获取的人前列腺腺瘤中的α1肾上腺素能、α2肾上腺素能和毒蕈碱胆碱能(MCh)结合位点进行特征分析。前列腺腺瘤标本取自9例接受膀胱前列腺切除术的无症状BPH男性患者、11例接受开放性前列腺切除术的有症状BPH男性患者以及11例接受经尿道前列腺切除术(TURP)的有症状BPH男性患者。定量症状评分分析和尿流率测定表明,接受膀胱前列腺切除术的男性不存在膀胱出口梗阻,而接受前列腺切除术的男性存在膀胱出口梗阻。在从无症状和有症状BPH男性患者获取的组织匀浆中,125I-Heat(α1肾上腺素能)和3H-NMS(MCh)结合位点的平均平衡解离常数(Kd)及平均密度相似。与从无症状BPH男性患者获取的标本相比,从有症状BPH男性患者获取的前列腺切除术标本中,3H-萝芙木碱(3H-Ra)的平均Kd显著更高(p<0.05)。与从无症状BPH男性患者获取的前列腺腺瘤相比,从有症状BPH男性患者获取的前列腺腺瘤中,3H-Ra(α2肾上腺素能)结合位点的密度显著更高(p<0.05)。α2肾上腺素能受体密度的差异是由开放性前列腺切除术标本中受体密度增加所致。α2肾上腺素能、α1肾上腺素能和MCh受体密度与前列腺重量或患者年龄之间无显著相关性。本研究表明,BPH男性患者膀胱下梗阻的发生与α1肾上腺素能或MCh受体结合位点的上调或结合亲和力改变无关。在接受开放性前列腺切除术的男性患者所获前列腺腺瘤中观察到的α2肾上腺素能受体上调的意义尚不清楚,需要进一步研究。

相似文献

1
Autonomic receptors in human prostate adenomas.人类前列腺腺瘤中的自主神经受体。
J Urol. 1990 Jan;143(1):179-85. doi: 10.1016/s0022-5347(17)39906-8.
2
Contractile properties of human prostate adenomas and the development of infravesical obstruction.
Prostate. 1989;15(2):105-14. doi: 10.1002/pros.2990150204.
3
Comparison of alpha 1 adrenoceptors in the prostate capsule of men with symptomatic and asymptomatic benign prostatic hyperplasia.有症状和无症状良性前列腺增生男性前列腺包膜中α1肾上腺素能受体的比较。
Br J Urol. 1991 May;67(5):493-8. doi: 10.1111/j.1464-410x.1991.tb15193.x.
4
The effect of electrocautery on neurotransmitter receptor binding assays in the canine prostate.电灼对犬前列腺神经递质受体结合测定的影响。
J Urol. 1988 Sep;140(3):668-71. doi: 10.1016/s0022-5347(17)41752-6.
5
The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.基质和上皮增生的相对比例与有症状的良性前列腺增生的发展有关。
J Urol. 1992 May;147(5):1293-7. doi: 10.1016/s0022-5347(17)37546-8.
6
Alpha 2 adrenergic receptors in hyperplastic human prostate: identification and characterization using [3H] rauwolscine.
J Urol. 1986 May;135(5):1038-42. doi: 10.1016/s0022-5347(17)45971-4.
7
Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia.人良性前列腺增生中α1肾上腺素能受体的特征分析
J Urol. 1984 Dec;132(6):1226-9. doi: 10.1016/s0022-5347(17)50110-x.
8
The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain.特拉唑嗪在人前列腺腺瘤和犬脑中的α肾上腺素能结合特性。
J Urol. 1988 Sep;140(3):664-7. doi: 10.1016/s0022-5347(17)41751-4.
9
Microwave thermotherapy for benign prostatic hyperplasia.微波热疗治疗良性前列腺增生症。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD004135. doi: 10.1002/14651858.CD004135.pub2.
10
Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue.
J Urol. 1984 Aug;132(2):397-402. doi: 10.1016/s0022-5347(17)49636-4.

引用本文的文献

1
Muscarinic receptor subtype mRNA expression in the human prostate: association with age, pathological diagnosis, prostate size, or potentially interfering medications?毒蕈碱受体亚型mRNA在人前列腺中的表达:与年龄、病理诊断、前列腺大小或潜在干扰药物的关联?
Naunyn Schmiedebergs Arch Pharmacol. 2014 Feb;387(2):207-14. doi: 10.1007/s00210-013-0934-4. Epub 2013 Nov 6.
2
Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy.坦索罗辛口服控释系统(OCAS)治疗良性前列腺增生。
Ther Clin Risk Manag. 2008 Feb;4(1):11-8. doi: 10.2147/tcrm.s86.
3
Pathophysiology of lower urinary tract symptoms in the aging male population.
老年男性人群下尿路症状的病理生理学
Rev Urol. 2005;7 Suppl 7(Suppl 7):S3-S11.
4
Pathophysiology of benign prostatic hyperplasia in the aging male population.老年男性人群良性前列腺增生的病理生理学
Rev Urol. 2005;7 Suppl 4(Suppl 4):S3-S12.
5
Management of bladder, prostatic and pelvic floor disorders.膀胱、前列腺及盆底疾病的管理
Neurotox Res. 2006 Apr;9(2-3):161-72. doi: 10.1007/BF03033935.
6
Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.膀胱、尿道和前列腺中的α1、α2和β肾上腺素能受体。
Br J Pharmacol. 2006 Feb;147 Suppl 2(Suppl 2):S88-119. doi: 10.1038/sj.bjp.0706619.
7
Norepinephrine contents of human prostatic hyperplasia: differences between pathological subtypes.人前列腺增生组织中去甲肾上腺素含量:病理亚型之间的差异
Int Urol Nephrol. 1996;28(1):61-6. doi: 10.1007/BF02550139.
8
Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.阿夫唑嗪,一种下尿路选择性α1肾上腺素能受体拮抗剂。
Br J Pharmacol. 1993 Aug;109(4):1282-9. doi: 10.1111/j.1476-5381.1993.tb13762.x.
9
Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery.介导人前列腺尿道和外周动脉收缩的不同α1肾上腺素能受体亚型的药理学证据。
Br J Pharmacol. 1994 Nov;113(3):723-8. doi: 10.1111/j.1476-5381.1994.tb17053.x.
10
G-proteins in alpha 1-adrenoceptor mediated prostatic smooth muscle contraction.
Urol Res. 1994;22(3):143-6. doi: 10.1007/BF00571840.